ATE92189T1 - Immunoglobulin-bestimmungsverfahren. - Google Patents

Immunoglobulin-bestimmungsverfahren.

Info

Publication number
ATE92189T1
ATE92189T1 AT88902897T AT88902897T ATE92189T1 AT E92189 T1 ATE92189 T1 AT E92189T1 AT 88902897 T AT88902897 T AT 88902897T AT 88902897 T AT88902897 T AT 88902897T AT E92189 T1 ATE92189 T1 AT E92189T1
Authority
AT
Austria
Prior art keywords
substrate
igm
exposing
igg
determination procedure
Prior art date
Application number
AT88902897T
Other languages
English (en)
Inventor
Philip Paul Mortimer
John Victor Parry
Original Assignee
Health Lab Service Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10615080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE92189(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Health Lab Service Board filed Critical Health Lab Service Board
Application granted granted Critical
Publication of ATE92189T1 publication Critical patent/ATE92189T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT88902897T 1987-04-02 1988-03-31 Immunoglobulin-bestimmungsverfahren. ATE92189T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878707839A GB8707839D0 (en) 1987-04-02 1987-04-02 Immunoglobulin assay method
PCT/GB1988/000251 WO1988007680A1 (en) 1987-04-02 1988-03-31 Immunoglobulin assay method
EP88902897A EP0355099B2 (de) 1987-04-02 1988-03-31 Immunoglobulin-bestimmungsverfahren

Publications (1)

Publication Number Publication Date
ATE92189T1 true ATE92189T1 (de) 1993-08-15

Family

ID=10615080

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88902897T ATE92189T1 (de) 1987-04-02 1988-03-31 Immunoglobulin-bestimmungsverfahren.

Country Status (6)

Country Link
EP (1) EP0355099B2 (de)
JP (1) JPH02503228A (de)
AT (1) ATE92189T1 (de)
DE (1) DE3882705T3 (de)
GB (1) GB8707839D0 (de)
WO (1) WO1988007680A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4865966A (en) * 1987-04-17 1989-09-12 New York University Method for detecting antibodies to human immunodeficiency virus
US5122446A (en) * 1987-04-17 1992-06-16 New York University Method for detecting antibodies to human immunodeficiency virus
US5447837A (en) * 1987-08-05 1995-09-05 Calypte, Inc. Multi-immunoassay diagnostic system for antigens or antibodies or both
DE3837616A1 (de) * 1988-11-05 1990-05-10 Behringwerke Ag Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aller immunglobulin-klassen und dazu geeignetes mittel
CA2023636A1 (en) * 1989-09-21 1991-03-22 Andrew S. Goldstein Oral immunoglobulin collection for immunoassay
US5103836A (en) * 1990-02-28 1992-04-14 Epitope, Inc. Oral collection device and kit for immunoassay
JP2760896B2 (ja) * 1991-04-11 1998-06-04 シーダーズ―サイナイ・メディカル・センター ＨＩＶ特異的ＩｇＭの検出のための免疫検定
US5165526A (en) * 1991-12-16 1992-11-24 Conklin Jr Dennis R Conveyor system with panels containing visual information
GB9211176D0 (en) * 1992-05-27 1992-07-08 Central Blood Lab Authority Assay
IL107628A0 (en) * 1992-11-18 1994-02-27 Calypte Inc Immunoassays for microorganisms associated with sexually transmitted diseases
GB2282884A (en) * 1993-04-14 1995-04-19 Int Murex Tech Corp Immunoassay
CA2137786A1 (en) * 1993-04-14 1994-10-27 Murex Diagnostics Corporation Immunoassay
WO1997002490A1 (en) * 1995-07-06 1997-01-23 Ochnio Jan J Assay for hepatitis a virus-specific antibodies
EP0888549B1 (de) * 1996-03-13 2000-05-03 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Verfahren zum nachweis von antikörpern gegen hav 3c proteinase
US5792605A (en) * 1996-07-05 1998-08-11 Ochnio; Jan J. Assay for Hepatitis A virus specific antibodies
JPH10246725A (ja) * 1997-03-03 1998-09-14 Mikio Nakayama 抗体又は抗原の検出方法
JPH1151936A (ja) * 1997-07-31 1999-02-26 Otsuka Pharmaceut Co Ltd 初感染の特異的検出方法及び検出用試薬キット
US7192778B2 (en) 1999-10-06 2007-03-20 Natan Michael J Surface enhanced spectroscopy-active composite nanoparticles
US8497131B2 (en) 1999-10-06 2013-07-30 Becton, Dickinson And Company Surface enhanced spectroscopy-active composite nanoparticles comprising Raman-active reporter molecules
WO2002079764A1 (en) 2001-01-26 2002-10-10 Nanoplex Technologies, Inc. Surface-enhanced spectroscopy-active sandwich nanoparticles
US8409863B2 (en) 2005-12-14 2013-04-02 Becton, Dickinson And Company Nanoparticulate chemical sensors using SERS
US7723100B2 (en) 2006-01-13 2010-05-25 Becton, Dickinson And Company Polymer coated SERS nanotag
JPWO2024204714A1 (de) * 2023-03-30 2024-10-03
CN118011006B (zh) * 2024-01-29 2024-10-01 武汉中生毓晋生物医药有限责任公司 用药患者血浆中抗人胸腺和/或淋巴细胞兔免疫球蛋白总IgG抗体浓度检测试剂盒及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273756A (en) * 1978-07-28 1981-06-16 Abbott Laboratories Immunoassay for class specific antibodies
JPS5931453A (ja) * 1982-07-14 1984-02-20 Fujirebio Inc 梅毒抗体の測定方法
FR2549230B1 (fr) * 1983-06-14 1986-04-11 Bio Merieux Procede de detection d'un oligomere dans un milieu liquide contenant des monomeres correspondants, dispositif pour la mise en oeuvre de ce procede et application notamment a la recherche d'allergenes
EP0170746A1 (de) * 1984-08-07 1986-02-12 Covalent Technology Corporation Test für Material mit biologischer Wirksamkeit
EP0211756A1 (de) * 1985-08-01 1987-02-25 Merck & Co. Inc. Assay für Varicella-Zoster-Virus (VZV)-Antikörper

Also Published As

Publication number Publication date
DE3882705D1 (de) 1993-09-02
GB8707839D0 (en) 1987-05-07
EP0355099B1 (de) 1993-07-28
WO1988007680A1 (en) 1988-10-06
DE3882705T3 (de) 1997-04-17
DE3882705T2 (de) 1993-12-02
JPH02503228A (ja) 1990-10-04
EP0355099B2 (de) 1996-12-04
EP0355099A1 (de) 1990-02-28

Similar Documents

Publication Publication Date Title
ATE92189T1 (de) Immunoglobulin-bestimmungsverfahren.
NL185309C (nl) Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens.
DK343679A (da) Immunologisk fremgangsmaade til bestemmelse af et immunkompleks i en vaeske samt det ved frmegangsmaaden anvendte diagnostiske middel
WO1998023955A3 (de) ANTIGENSPEZIFISCHER IgM-NACHWEIS
NO970292D0 (no) Bestemmelse av et spesifikt immunoglobulin ved anvendelse av multiple antigener
NO992578L (no) Antigenspesifikk IgG-deteksjon
DK155967C (da) Fremgangsmaade samt kit til bestemmelse af antistoffer mod oploeselige antigener
ATE79678T1 (de) Bestimmung von monokinen.
Oudin [9] Immunochemical analysis by antigen-antibody precipitation in gels
ATE16219T1 (de) Immunologisches latex-agglutinationsverfahren.
DK327289A (da) Diagnostiske metoder og systemer til kvantificering af apo ai
FR2676123B1 (fr) Complexe agglutinant et reactif d'identification d'antigenes sur les parois cellulaires.
DE3686717D1 (de) Immuntestverfahren.
ATE174688T1 (de) Verfahren zur bestimmung von antigenen oder antikörpern in gegenwart eines immunkomplexes
ATE199596T1 (de) Diagnostisches reagenz für hepatitis c
DK230485D0 (da) Fremgangsmaade til bestemmelse af atl virusantistof og reagens dertil
EP0433274A4 (de) Cea-immunanalyse, frei von fälschlich positiven menschlichen anti-maus-antikörpern.
ITMI930477A1 (it) Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio
ES2029890T3 (es) Inmunoensayo.
NO870461D0 (no) Reagens for paavisning av antistoff mot virusantigener.
NO881998D0 (no) Fremgangsmaate til kvantitativ bestemmelse av serumproteiner i kroppsvaesker, og middel til gjennomfoering av fremgangsmaaten.
DK0519536T3 (da) Diagnostisk fremgangsmåde
DE68917732D1 (de) Immuntestverfahren von chondrocalcin.
ATE105412T1 (de) Verfahren zur immunologischen bestimmung von bakterien der gattung aeromonas und der spezies vibrio cholerae.